Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G2MW
|
||||
Former ID |
DAP000969
|
||||
Drug Name |
Icosapent
|
||||
Synonyms |
Icosapento; Icosapentum; Eicosapentaenoic acid; Icosapentaenoic acid; Timnodonic acid; E0441; BML3-B01; Icosapento [INN-Spanish]; Icosapentum [INN-Latin]; EICOSAPENTAENOIC ACID (20:5 n-3); All cis-5,8,11,14,17-Eicosapentaenoic Acid; All cis-5,8,11,14,17-Icosapentaenoic Acid; Cis-5,8,11,14,17-EPA; Cis-5,8,11,14,17-Eicosapentaenoic acid; Cis-Delta(5,8,11,14,17)-eicosapentaenoic acid; All-cis-icosa-5,8,11,14,17-pentaenoic acid; Cis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid; (Z,Z,Z,Z,Z)-5,8,11,14,17-eicosapentaenoic acid; (all-Z)-5,8,11,14,17-Eicosapentaenoic acid; (all-Z)-delta5,8,11,14,17-Eicosapentaenoic acid; (all-cis)-5,8,11,14,17-Eicosapentaenoic acid; 5,8,11,14,17-EICOSAPENTAENOIC ACID; 5,8,11,14,17-Eicosapentaenoic acid (6CI); 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-(9CI); 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)-(8CI); 5,8,11,14,17-Icosapentaenoic acid; 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid; 7F8BF016-B146-4F72-A52E-B9298BA3A9AB
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Dietary supplement
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H34O2
|
||||
InChI |
InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-
|
||||
InChIKey |
SSQPWTVBQMWLSZ-AAQCHOMXSA-N
|
||||
CAS Number |
CAS 10417-94-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7848954, 14851023, 24132245, 44929533, 47205492, 49964825, 57373458, 71821310, 77834595, 87569697, 92308211, 99006112, 104179160, 117663994, 125307497, 125309298, 126666714, 135029488, 135114359, 135727811, 143077352, 144076075, 160686878, 162064799, 162262088, 175266496, 175268968, 175427134, 175611317, 178104013, 179117039, 223445352, 223680105, 224382965, 226494419, 242084018, 250134289, 252466658, 252816326
|
||||
ChEBI ID |
ChEBI:28364
|
||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Binder | [535691] | |
References | |||||
Ref 542465 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7441). | ||||
Ref 550112 | Drug information of Icosapent, Health Canada, 2007. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.